UCSF study suggests stress response inhibitor could treat prostate cancer

A new study from University of California San Francisco researchers suggests that releasing the "brakes" on a tumor's stress regulation system by inhibiting eukaryotic translation initiation factor 2A (EIF2A) could help treat metastatic prostate cancer.

Aggressive cancers such as metastatic prostate cancer are characterized by increased

Read the full 450 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers